Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 6013
Selected: 0
NCT IDTitle
NCT00252967Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
NCT00762463Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis
NCT05375955A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.
NCT02531815Dose Escalation Study of PF-06741086 In Healthy Subjects
NCT00631618Clinical Trial of Sutent to Treat Metastatic Melanoma
NCT00884390Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings
NCT02955160A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
NCT00538889Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects
NCT00634790A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks
NCT00167960Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit
NCT02052726A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
NCT00874185Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk
NCT03845517A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
NCT04436120Treatment Resistance Following Anti-cancer Therapies
NCT00799682Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
NCT07231978A Study to Learn How Different Forms of the Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults
NCT00852397A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients
NCT00446797Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain
NCT02431897Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen
NCT06256510A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam
NCT01020526Pregabalin In Adolescent Patients With Fibromyalgia
NCT00542035A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
NCT06703190Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine
NCT03637790Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842.
NCT03535506Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery
NCT00454298Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement
NCT02724163International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
NCT00913458Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
NCT02227550Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
NCT02981472A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
NCT00774267Study Evaluating Changes In Mammographic Breast Density
NCT06724536Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML
NCT04362072Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
NCT03938792Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
NCT01480219Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g
NCT00472836Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug
NCT02346344Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT00640692Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial
NCT01274663A Study Of PF-05175157 In Healthy Volunteers
NCT00918632Food Effect Study Of AG-013736 In Healthy Volunteers
NCT01753245Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.
NCT01290445Varenicline Pregnancy Cohort Study
NCT04002830A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
NCT01001936Study Evaluating SKI-606 in Subject With Solid Tumors
NCT01262677Once-A-Day Pregabalin For Partial Seizures
NCT00795509Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).
NCT01125631Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
NCT01513928A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects
NCT04735367Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
NCT03329092A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.